Fuquan Capital Management Stock (OTC: FQCC)

Latest news for Fuquan Capital Management (OTC:FQCC) Stock

Fuquan Capital Management Inc is a green technology company. The company is specialized in green energy audits, green engineering, design-build and life safety compliance. The company's key products include algae biomass, algae cake, astaxanthin, omega-3, and algae oil. It serves nutraceutical, pharmaceutical, and health and wellness markets.

FUQUAN CAPITAL MGMT INC by Fuquan Capital Management, Inc.

Fuquan Capital Management Inc

News

XCHG Says Its Gridlink Has Achieved Certification In The US, Setting New Standards For Safety And Efficiency

Contracts

RDCM

Radcom Entered Into Multi-year, Low Eight-Figures, U.S. Dollars Agreement With Existing North American Customer To Further Develop Advanced Software Features For Its Radcom Ace Solution

CARA

Cara Therapeutics Announces 1-for-12 Reverse Stock Split Of Its Outstanding Shares Of Common Stock And Reduction In Total Number Of Authorized Shares From 200M To 16.66M, Which Will Be Effective On December 30

The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Tim SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIMB#NYSE">TIMB</a>)</h3>
<ul>
<li>On Dec. 19, Goldman Sachs analyst Vitor Tomita maintained TIM with a Neutral and lowered the price target from $16.2 to $14. The company's stock fell around 14% over the past month and has a <a href="https://www.benzinga.com/quote/TIMB">52-week low of $11.76</a>.</li>
<li>RSI Value: 28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>TIMB Price Action: Shares of Tim fell 2.2% to close at $11.81 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1">TIMB news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="892" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061446/image-215.png" alt="" class="wp-image-709045" style="width:599px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061446/image-215.png 892w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061446/image-215-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061446/image-215-768x716.png 768w" sizes="(max-width: 892px) 100vw, 892px" /></a></figure>
<h3 class="wp-block-heading">Gray Television Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTN#NYSE">GTN</a>)</h3>
<ul>
<li>On Dec. 18, Atlanta Braves partnered with Gray Media to simulcast 15 regular season games. The company's stock fell around 28% over the past month and <a href="https://www.benzinga.com/quote/GTN">has a 52-week low</a> of $2.91.</li>
<li>RSI Value: 24</li>
<li>GTN Price Action: Shares of Gray Television gained 3% to close at $3.12 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1">GTN stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="912" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061540/image-216.png" alt="" class="wp-image-709050" style="width:545px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061540/image-216.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061540/image-216-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061540/image-216-768x701.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<h3 class="wp-block-heading">Electronic Arts Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>)</h3>
<ul>
<li>On Dec. 18, Stifel analyst Drew Crum downgraded Electronic Arts from Buy to Hold and maintained the price target of $167. The company's stock fell around 9% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/NEE">low of $124.96</a>.</li>
<li>RSI Value: 26</li>
<li>EA Price Action: Shares of Electronic Arts slipped 0.1% to close at $149.07 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1">breakout in EA shares</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="872" height="848" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061654/image-217.png" alt="" class="wp-image-709056" style="width:567px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061654/image-217.png 872w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061654/image-217-300x292.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27061654/image-217-768x747.png 768w" sizes="(max-width: 872px) 100vw, 872px" /></a></figure>
Read This More: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42697989/dow-edges-higher-in-thin-holiday-trading-fear-declines-among-us-investors-but-fear-greed-index-remains-in-fear-zone">Dow Edges Higher In Thin Holiday Trading As Tesla, Apple Surge: Investor Sentiment Improves, But Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

TIMB

Top 3 Tech And Telecom Stocks That May Rocket Higher In Q4

AerCap Holdings Inks Sale And Leaseback Agreement For One New Boeing 787-9 Aircraft With TAAG Angola Airlines, Aircraft Is Scheduled To Deliver To TAAG In February 2025

HC Wainwright &amp; Co. analyst Ed Arce reiterates Assembly Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASMB#NASDAQ">ASMB</a>) from Neutral to Neutral.

Reiteration

Analyst Ratings

ASMB

HC Wainwright & Co. Reiterates Neutral on Assembly Biosciencesto Neutral

SRFM

Surf Air Mobility Says Chairman Carl Albert, And Co-founder Sudhin Shahani, Purchased 14,500 Shares And 17,237 Shares, Respectively, Of The Company's Common Stock, For An Aggregate Purchase Price Of Approximately $110,000, In Open Market Transactions

AMED

Amedisys-UnitedHealth Announced In Filing Earlier, They Extended Merger Deadline Until December 31, 2025

On Thursday, December 26, U.S. markets closed mixed. The Dow Jones Industrial Average rose slightly, marking its fifth straight gain despite light trading and higher Treasury yields. The S&amp;P 500 and Nasdaq slipped, breaking recent streaks. Megacap tech stocks faced pressure, though Apple edged closer to a $4 trillion valuation. Seasonal trends and optimism around AI-driven profits continue to support year-end market hopes.
In economic data, U.S. initial jobless claims dropped by 1,000 in the second week of December, reaching 219,000, slightly below market expectations of 224,000.
S&amp;P 500 sectors gained, led by healthcare, financial, and real estate stocks, while consumer discretionary and communication services declined.
The Dow Jones Industrial Average was up 0.07% and closed at 43,325.80, the S&amp;P 500 closed lower by 0.04% at 6,037.59, and the Nasdaq Composite fell 0.05% to finish at 20,020.36.
Asia Markets Today
<ul>
<li>On Friday, Japan&#8217;s Nikkei 225 gained 1.77% and ended the session at 40,277.50, led by gains in the Shipbuilding, Automobiles &amp; Parts, and Chemical, Petroleum &amp; Plastic sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 closed higher by 0.50% at 8,261.80, led by gains in the Gold, Consumer Discretionary and Financials sectors.</li>
<li>India&#8217;s Nifty 50 rose 0.35% to 23,832.45, and Nifty 500 was up 0.10%, closing at 22,453.25, led by gains in the Auto, IT, and Banking sectors.</li>
<li>China&#8217;s Shanghai Composite rose 0.06% to close at 3,400.14, while the Shenzhen CSI 300 slid 0.16%, finishing the day at 3,981.03.</li>
<li>Hong Kong&#8217;s Hang Seng closed the session lower by 0.04% at 20,090.46.</li>
</ul>
Eurozone at 06:00 AM ET
<ul>
<li>The European STOXX 50 was up 0.56%.</li>
<li>Germany&#8217;s DAX rose 0.38%.</li>
<li>France&#8217;s CAC gained 0.56%.</li>
<li>U.K.&#8217;s FTSE 100 was trading higher by 0.08%.</li>
</ul>
Commodities at 06:00 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 0.86% at $70.23/bbl, and Brent was up 0.76% at $73.41/bbl.</li>
<li>Oil prices edged higher, supported by expectations of a stimulus-driven economic recovery in China and declining U.S. crude inventories, but gains were limited by a stronger U.S. dollar.</li>
<li>Natural Gas rose 2.98% to $3.418.</li>
<li>Gold was trading lower by 0.48% at $2,641.16, Silver was down 0.80% to $30.340 and slid 0.28% to $4.1158.</li>
</ul>
U.S. Futures at 06:00 AM ET
Dow futures were down 0.31%, S&amp;P 500 futures declined 0.36%, and Nasdaq 100 futures slid 0.38%.
Forex at 06:00 AM ET
<ul>
<li>The U.S. Dollar Index was down 0.06% to 108.07, USD/JPY fell 0.16% to 157.75, and USD/AUD rose 0.19% to 1.6101.</li>
<li>The U.S. dollar is set for a 7% annual gain, driven by strong growth and cautious Federal Reserve rate cuts, while the yen and euro weakened amid diverging global monetary policies.</li>
</ul>
Image via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Europe And Asia Markets Gain; Dollar Set For 7% Annual Gain - Global Markets Today While Us Slept

Shares of&nbsp;GameStop Corp&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) saw a decline of 2.09% during pre-market hours following an initial surge driven by social media activity as per <a href="https://pro.benzinga.com">Benzinga Pro.</a>
The stock&#8217;s initial rise was triggered by a post from&nbsp;Keith Gill, also known as &#8220;Roaring Kitty,&#8221; who shared a mysterious image on X, formerly known as Twitter. This post, made on Dec. 25, featured a wrapped ‘Christmas Present' and sparked speculation among retail investors, leading to a 7.68% increase&nbsp;in after-hours trading on Robinhood,&nbsp;with shares reaching a peak of $33.50. However, the stock later declined as investors took profits.
Meme stocks like GameStop often gain momentum&nbsp;through viral popularity and speculative&nbsp;trading, which are heavily influenced by social media and active retail communities. While these stocks can offer significant gains, they are also known for their high volatility and the risk of substantial losses.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/24/12/42638957/warren-buffetts-timeless-advice-if-youre-gonna-do-dumb-things-because-your-stock-goes-down-you-shouldnt-own-a-stock-at-all?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Warren Buffett's Timeless Advice For Investing $10,000: &#8216;If You're Gonna Do Dumb Things Because Your Stock At All&#8217;</a>
Despite the recent surge in activity, GameStop&#8217;s stock holds&nbsp;a consensus price target of&nbsp;$10 from analysts, with&nbsp;Wedbush&nbsp;maintaining this target since Sep. 11. The&nbsp;average price target of $9.33&nbsp;suggests a potential downside of 71.10% from current levels, according to the latest analyst ratings.
The recent social media-driven surge in GameStop shares is reminiscent of the 2021 meme stock phenomenon, where retail investors, fueled by platforms like Reddit, drove up the prices of certain stocks, including GameStop. 
Meme stocks gain their fame through viral popularity and speculative trading, fueled primarily by social media buzz and active retail investor communities. While they can deliver quick, substantial gains, they also carry extreme volatility and the potential for heavy losses.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/insights/options/24/12/42671143/smart-money-is-betting-big-in-smci-options?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Smart Money Is Betting Big In SMCI Options</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

General

GameStop Shares Dip In Friday's Premarket After Surging Nearly 6% In Last Session, Fueled By Roaring Kitty's 'Christmas Present'

Planemaker Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) is reportedly witnessing an increased number of its engineers leaving for space companies. 
What Happened: The average tenure of a Boeing engineer has dropped to 12.6 years from 16.4 years over the last decade, the Financial Times <a href="https://www.ft.com/content/5dea45ef-25c7-4b5c-ad8a-9984ec66bf53">reported</a>, citing data from the Society of Professional Engineering Employees in Aerospace, a union representing 12,000 Boeing engineers. As per union data, the tenure is shortening in every age bracket.
The departure of engineering talent could make it harder for the company to launch a new plane, the report noted, while adding that the struggling plane maker is serving as a good place for space companies like SpaceX and Blue Origin to poach talent from.
While rival space companies continue to aim big and develop new vehicles, Boeing is <a href="https://www.benzinga.com/tech/24/12/42377203/boeing-chief-lobbyist-ziad-ojakli-leaves-troubled-planemaker-report">yet to announce a new plane</a>, FT noted. 
"Boeing is an airplane company and at the right time in the future, we need to develop a new airplane. But we have a lot of work to do before then," Ortberg said during the company&#8217;s third-quarter earnings call.
Boeing did not immediately respond to <a href="http://pro.benzinga.com/dashboard">Benzinga&#8217;s</a> request for comment.
Why It Matters: Boeing has been struggling since the start of the year when a door panel flew off an Alaska Airlines jet manufactured by the company. 
Later in the year, technical issues were identified with the Starliner spacecraft manufactured by the company, causing space agency NASA to opt out of bringing back the two astronauts who flew on Starliner to the International Space Station on the same spacecraft. The astronauts are now slated to return to Earth on a SpaceX Dragon spacecraft no earlier than March. 
Boeing CEO Kelly Ortberg said in October that Boeing would downsize its workforce by 10%. The layoff is <a href="https://www.benzinga.com/markets/equities/24/10/41301576/boeing-announces-10-workforce-reduction-amidst-ongoing-struggles-impacting-nearly-17k-employees">expected to impact nearly 17,000 jobs</a>. Ortberg then said that the layoffs are necessary to align with Boeing's financial reality and future recovery plans.
Price Action: Boeing shares closed up 0.6% at $180.38 on Thursday. The stock is down 28.4% year-to-date, according to data from Benzinga Pro. 
Boeing has a consensus price target of $197.85 based on the ratings of 23 analysts tracked by Benzinga. The analysts have a consensus &#8220;buy&#8221; rating on the stock.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="923" height="338" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27060611/image-214.png" alt="" class="wp-image-709030" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27060611/image-214.png 923w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27060611/image-214-300x110.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27060611/image-214-768x281.png 768w" sizes="(max-width: 923px) 100vw, 923px" /></figure>
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42668333/tesla-model-x-lucid-gravity-or-rivian-r1s-which-three-row-electric-suv-is-a-better-buy" target="_blank" rel="noreferrer noopener">Tesla Model X, Lucid Gravity Or Rivian R1S: Which Three-Row Electric SUV Is A Better Buy?</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

Boeing Engineers Leave Struggling Planemaker For Space Companies: Report

Burford Capital Reveals Issuance Of New Ordinary Shares In Connection With Long Term Incentive Plan

IDYA

IDEAYA Biosciences Says Its Board Of Directors Granted Non-qualified Stock Options To Purchase An Aggregate Of 31,400 Shares Of  Company's Common Stock To A Newly Hired Employee

Management

So-Young International Has Appointed Ms. Gefei Li As COO

BeiGene, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGNE#NASDAQ">BGNE</a>, HKEX: 06160, SSE: 688235))), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) has approved TEVIMBRA&#xAE; (tislelizumab-jsgr), in combination with platinum and fluoropyrimidine-based chemotherapy, for the first-line treatment of unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G/GEJ) in adults whose tumors express PD-L1 (≥1).
"Today's FDA approval of TEVIMBRA for the treatment of gastric or gastroesophageal junction cancers in PD-L1 positive adult patients marks a significant step forward in our mission to deliver transformative therapies to patients with cancer," said Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeiGene. "This is the second U.S. approval for TEVIMBRA this year, underscoring its potential to address critical needs in oncology. We remain deeply grateful to the patients, clinicians, and researchers whose commitment and courage have made this progress possible—and we look forward to building on this momentum in 2025."
The additional indication for first-line G/GEJ cancers is based on results from BeiGene's RATIONALE-305 (<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03777657&amp;esheet=54171021&amp;newsitemid=20241227403101&amp;lan=en-US&amp;anchor=NCT03777657&amp;index=1&amp;md5=30e9cd81ec8a563b14e02fe5d32103f4">NCT03777657</a>), a randomized, double-blind, placebo-controlled, global Phase 3 trial to evaluate the efficacy and safety of TEVIMBRA in combination with chemotherapy as a first-line treatment for adult patients with advanced unresectable or metastatic G/GEJ cancer. The study met its primary endpoint and demonstrated a statistically significant and clinically meaningful overall survival (OS) benefit with a median OS of 15.0 months for patients treated with TEVIMBRA in combination with the investigator's choice of chemotherapy compared to 12.9 months for patients treated with placebo plus chemotherapy (n=997; HR: 0.80 [95% CI: 0.70, 0.92]; P=0.0011), resulting in a 20% reduction in the risk of death.
The pooled safety data in the application included 1,972 patients who received TEVIMBRA monotherapy in two randomized open-label, active-controlled studies (RATIONALE-302, BGB-A317-303) and five open-label, single-arm studies (BGB-A317-208, BGB-A317-204, BGB-A317-203, BGB-A317-102, BGB A317_Study_001), which enrolled 307 patients with esophageal squamous cell carcinoma and 1,665 patients with advanced or recurrent tumors. The most common Grade 3 or 4 adverse reactions for TEVIMBRA given in combination with chemotherapy were neutropenia, thrombocytopenia, anemia, fatigue, hypokalemia, hyponatremia, pneumonia, decreased appetite, rash, lymphopenia, alanine aminotransferase increased, aspartate aminotransferase increased, diarrhea, pneumonitis, and hepatitis.
TEVIMBRA is also approved in the U.S. as monotherapy for the treatment of adult patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) after prior systemic chemotherapy that did not include a PD-(L)1 inhibitor. An additional Biologics License Application (BLA) is under review at the FDA for the first-line treatment of adult patients with locally advanced unresectable or metastatic ESCC.

Government

Regulations

BGNE

BeiGene Gains FDA Nod for TEVIMBRA, Marking Key Progress in Oncology Treatments

Larry Ellison closes out a remarkable year as Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) sees its strongest stock rally since the dot-com era, adding nearly $75 billion to Ellison&#8217;s net worth.
What Happened: Oracle&#8217;s shares have climbed 63% in 2024, significantly outpacing the S&amp;P 500&#8217;s 27% gain. This boost has elevated Ellison&#8217;s net worth to over $217 billion, positioning him just behind&nbsp;Elon Musk&nbsp;and&nbsp;Jeff Bezos&nbsp;in global wealth rankings, according to Forbes, CNBC <a href="https://www.cnbc.com/2024/12/26/larry-ellison-net-worth-jumps-on-oracle-gains-as-he-turns-80.html">reported</a> on Friday.
Oracle&#8217;s success is linked to its strategic moves in the AI sector, leveraging its cloud infrastructure technology. Partnerships with companies like OpenAI and Meta have bolstered Oracle&#8217;s market presence. Despite a recent earnings report that fell short of expectations, Ellison remains optimistic about future growth.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/24/12/42678673/michael-jordan-sells-his-massive-luxury-mansion-for-9-5-million-but-it-took-12-years-to-find-a-buyer-and-he-spent-50-million-building-it?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Michael Jordan Sells His Massive Luxury Mansion For $9.5 Million – But It Took 12 Years To Find A Buyer And He Spent $50 Million Building It</a>
Oracle&#8217;s revenue is projected to grow by about 10% in the current fiscal year, marking its second-strongest expansion since 2011. Ellison&#8217;s leadership and strategic partnerships, including recent collaborations with Microsoft and Amazon, are expected to drive further growth.
Why It Matters: The rise in Oracle&#8217;s stock is largely attributed to its strategic positioning in the AI sector.&nbsp;Dan Ives highlighted <a href="https://www.benzinga.com/markets/equities/24/12/42404918/oracle-positioned-to-benefit-from-enterprise-revolution-says-dan-ives-the-software-phase-of-the-ai-revolution-is-now-here">Oracle&#8217;s potential to benefit</a> from the enterprise software AI revolution. He emphasized Oracle&#8217;s competitive edge in the enterprise space, particularly its cloud infrastructure and software stack.
Despite a&nbsp;<a href="https://www.benzinga.com/news/earnings/24/12/42400723/oracle-q2-earnings-revenue-miss-eps-miss-ai-growth-ellison-says-opportunity-is-unimaginable">recent earnings report</a>&nbsp;that missed expectations, Oracle reported a 9% year-over-year increase in second-quarter revenue. Ellison described the AI growth opportunity as &#8220;unimaginable,&#8221; underscoring the company&#8217;s focus on expanding its cloud and AI capabilities.
Oracle&#8217;s strategic moves and partnerships in AI and cloud technology are expected to continue driving its growth, making it a key player in the evolving tech landscape.
Price Action: Oracle was trading 0.21% lower on Friday during pre-market hours, as per <a href="https://pro.benzinga.com">Benzinga Pro</a>. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42668043/if-you-gave-your-loved-ones-a-150-bitcoin-christmas-gift-in-2022-itd-be-worth-more-than-what-an-average-american-spends-on-the-holiday-in-2024?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">If You Gave Your Loved Ones A $150 Bitcoin Christmas Gift In 2022, It&#8217;d Be Worth More Than What An Average American Spends On The Holiday In 2024</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Flickr

ORCL

Larry Ellison's Wealth Soars By $75B, Trailing Only Elon Musk And Jeff Bezos, As Oracle Posts Its Biggest Stock Rally Since The Dot-Com Era

Leerink Partners analyst Faisal Khurshid maintains Kymera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) with a Outperform and maintains $60 price target.

Price Target

KYMR

Leerink Partners Maintains Outperform on Kymera Therapeutics, Maintains $60 Price Target

SpaceX CEO Elon Musk on Thursday applauded the contribution of German scientists including Wernher von Braun in America&#8217;s space race against China. 
What Happened: &#8220;Indeed. Until they were applied to the US space program, America was losing the space race badly,&#8221; Musk wrote in a post on X. 
Earlier this week, Musk had mourned the shortage of engineering talent in America. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Indeed. Until they were applied to the US space program, America was losing the space race badly.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1872174980240462082?ref_src=twsrc%5Etfw">December 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;There is a permanent shortage of excellent engineering talent. It is the fundamental limiting factory in Silicon Valley,&#8221; he said. While his companies would prefer to hire Americans, there is a shortage in the country of talented engineers who are motivated in the U.S., he said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">There is a permanent shortage of excellent engineering talent. It is the fundamental limiting factor in Silicon Valley.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1871956518213656728?ref_src=twsrc%5Etfw">December 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The U.S. hired several German scientists for the development of its space program including Wernher von Braun after World War 2&nbsp;as part of&nbsp;Operation Paperclip, a secret United States intelligence program. 
A former Nazi party member, von Braun developed the rocket that launched United States&#8217; first space satellite Explorer 1. He was also key to developing the Saturn V launch vehicle which enabled the U.S. to send humans to the Moon under its Apollo program. As of today,&nbsp;the Saturn V remains the only launch vehicle to have carried humans beyond&nbsp;low Earth orbit&nbsp;(LEO).
Musk&#8217;s SpaceX is currently testing and developing its <a href="https://www.benzinga.com/news/24/05/39032543/spacex-ceo-elon-musk-says-gigantic-starship-to-get-even-taller-with-3x-more-thrust-than-saturn-v">Starship launch vehicle</a> aimed at taking humans to the Moon and further beyond. 
While NASA is looking forward to landing humans back on the surface of the Moon after a gap of over 50 years with the help of a&nbsp;<a href="https://www.benzinga.com/24/11/42108681/spacex-shows-off-conceptual-version-of-starship-which-will-help-humans-land-back-on-moon-in-over-50-yrs" target="_blank" rel="noreferrer noopener">custom version of Starship</a>, Musk is dreaming of taking&nbsp;<a href="https://www.benzinga.com/news/24/09/40770222/elon-musk-sets-2026-for-starships-first-uncrewed-mars-mission-targeting-successful-landing" target="_blank" rel="noreferrer noopener">humans to the planet Mars</a>&nbsp;aboard Starship.
The company has<a href="https://www.benzinga.com/general/space/24/12/42477647/elon-musk-reveals-spacexs-new-starship-spacecraft-is-easier-to-manufacture-and-less-susceptible-to-high-heating-ahead-of-7th-test-flight"> completed six flight tests</a> of the Starship to date but none with a payload. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42697605/byd-offers-discounts-of-up-to-115-on-select-evs-as-year-end-nears">BYD Offers Discounts Of Up To 11.5% On Select EVs As Year End Nears</a></li>
</ul>
Photo courtesy: Shutterstock

SPACE

Elon Musk Applauds Contribution Of German Scientist Wernher Von Braun To America's Space Program

The cryptocurrency market could experience major volatility following the largest Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) options expiry in history on Friday.
What Happened: According to leading cryptocurrency <a href="https://www.deribit.com/statistics/BTC/metrics/options">derivatives exchange</a> Deribit, Bitcoin options contracts, with nearly $14.38 billion in notional value expired at 3:00 a.m. ET.
This figure accounted for 70% of the total Open Interest for BTC options across different expiration dates.
Options are derivatives that give the buyer of the contract the right to buy or sell the underlying asset at a predetermined price and date. Typically, high Open Interest in options trading indicates that there are many market participants and new money is entering the market.
A call option gives the purchaser the right to buy an asset, while a put option allows them to sell assets at an agreed-upon price. As of this writing, the put/call ratio was 0.61, indicating a bullish sentiment as more traders were betting on price increases.
The next most significant date for traders is set for Jan. 31, when around $5.48 billion worth of options will expire.
See Also:&nbsp;<a href="https://www.benzinga.com/24/12/42697066/vivek-ramaswamys-strive-applies-for-bitcoin-bond-etf-that-will-track-microstrategys-convertible-securities-market">Vivek Ramaswamy&#8217;s Strive Applies For &#8216;Bitcoin Bond&#8217; ETF That Tracks MicroStrategy&#8217;s Convertible Securities Market</a>
Why It Matters: Talking to Benzinga previously, Deribit&nbsp;CEO&nbsp;Luuk Strijers had <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42655154/84000-is-bitcoins-worst-case-options-trading-firm-ceo-says">flagged $84,000</a> as the "max pain" level for Bitcoin, hinting at Bitcoin&#8217;s potential drop to this level.
Max pain price is the price at which most option holders would experience the biggest financial loss when an option expires.
Additionally, Sean McNulty, director of trading at liquidity provider Arbelos Markets, was <a href="https://www.bloomberg.com/news/articles/2024-12-27/bitcoin-btc-rally-fizzles-as-token-s-record-breaking-year-winds-down?srnd=phx-markets">quoted </a>by Bloomberg as suggesting that the market could become choppy following the expiry.
Price Action: At the time of writing, Bitcoin was exchanging hands at $96,724.39, up 1.43% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42696957/all-vitalik-buterin-wanted-for-xmas-was-a-hippopotamus-ethereum-co-founder-is-now-the-adoptive-father-of-viral-sensation-moo-deng">All Vitalik Buterin Wanted For Xmas Was A Hippopotamus — Ethereum Co-Founder Is Now The Adoptive Father Of Viral Sensation Moo Deng</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Options Worth Over $14 Billion Expired Today, One Of The Biggest Events In History: Here's What Crypto Investors Should Expect

Shares of Evaxion Biotech A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) rose sharply in today's pre-market trading after the company applied for a patent for vaccines targeting <a href="https://www.benzinga.com/quote/EVAX/news">Neisseria gonorrhoeae</a>.
Evaxion Biotech shares jumped 62% to $1.37 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Intrusion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) gained 177% to $1.23 in pre-market trading after surging around 22% on Thursday.</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) gained 79.6% to $2.55 in pre-market trading after gaining 100% on Thursday.</li>
<li>Rail Vision Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVSN#NASDAQ">RVSN</a>) shares jumped 56.4% to $1.21 in pre-market trading after jumping 68% on Thursday.</li>
<li>Solid Power, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDP#NASDAQ">SLDP</a>) gained 41.5% to $2.76 in pre-market trading after jumping around 30% on Thursday.</li>
<li>Quantum-Si incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) rose 38.2% to $2.97 in pre-market trading after gaining around 65% on Thursday.</li>
<li>AEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) gained 36.7% to $1.75 in pre-market trading after surging around 13% on Thursday.</li>
<li>T Stamp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDAI#NASDAQ">IDAI</a>) gained 29.5% to $0.6999 in pre-market trading after gaining more than 21% on Thursday.</li>
<li>Ondas Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) rose 26.6% to $3.18 in pre-market trading after climbing around 24% on Thursday.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) gained 17.7% to $12.01 in pre-market trading after gaining over 14% on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Viracta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRX#NASDAQ">VIRX</a>) fell 21.8% to $0.1851 in pre-market trading as the company said its board has initiated a process to explore a broad range of strategic alternatives. The company announced plans to close its ongoing pivotal Phase 2 clinical trial of Nana-val in Relapsed/Refractory EBV + Lymphomas.</li>
<li>Meridian Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRBK#NASDAQ">MRBK</a>) shares tumbled 20.5% to $11.00 in pre-market trading.</li>
<li>Quest Resource Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRHC#NASDAQ">QRHC</a>) declined 19.4% to $5.00 in pre-market trading after jumping around 5% on Thursday.</li>
<li>Millennium Group International Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGIH#NASDAQ">MGIH</a>) shares dipped 14.5% to $2.5400 in pre-market trading after surging 94% on Thursday.</li>
<li>MicroAlgo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares fell 10.5% to $2.55 in pre-market trading after surging over 62% on Thursday.</li>
<li>Neuphoria Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEUP#NASDAQ">NEUP</a>) fell 10.4% to $3.99 in pre-market trading after dipping over 32% on Thursday.</li>
<li>West Bancorporation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTBA#NASDAQ">WTBA</a>) shares fell 9.6% to $20.00 in pre-market trading.</li>
<li>LuxUrban Hotels Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXH#NASDAQ">LUXH</a>) fell 9.2% to $0.8999 in today's pre-market trading after gaining over 3% on Thursday.</li>
<li>Luokung Technology Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKCO#NASDAQ">LKCO</a>) dipped 9.1% to $1.69 in pre-market trading after gaining over 8% on Thursday.</li>
<li>Matrix Service Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) fell 8.9% to $11.14 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42698100/constellium-viracta-therapeutics-and-3-stocks-to-watch-heading-into-friday">Constellium, Viracta Therapeutics And 3 Stocks To Watch Heading Into Friday</a></li>
</ul>

EVAX

IDAI

INTZ

LIDR

LKCO

LUXH

MGIH

MLGO

MRBK

MTRX

NEUP

ONDS

QRHC

RVSN

SLDP

VIRX

WTBA

Why Evaxion Biotech Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket

Fuquan Capital Management

Comments

Fuquan Capital Management

News

Latest news for Fuquan Capital Management (OTC:FQCC) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga